Maintained malnutrition produces a progressive decrease in (OPG)/RANKL ratio and leptin levels in patients with anorexia nervosa
Authors:
- V. BarriosVBV. Barrios
- M. T. García de ÁlvaroMÁM. T. García de Álvaro
- M. LefortMLM. Lefort
- C. Méndez‐DávilaCMC. Méndez‐Dávila
- J. ArgenteJAJ. Argente
- C. de la PiedraCPC. de la Piedra
- 1 January 2007
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 67 (4) , 387-393
Abstract
Osteoprotegerin (OPG) and receptor activator of nuclear factor-kappaB ligand (RANKL) are key factors in bone remodeling in patients with anorexia nervosa (AN) and osteopenia. The purpose of this study was to investigate basal serum levels of OPG, RANKL and leptin, as well as bone mineral density (BMD) measured by DEXA at lumbar vertebrae L1-L4, and their evolution during one year in two groups of patients with AN. Group I included 10 adolescent girls suffering from malnutrition and secondary amenorrhea with an evolution of more than one year at the beginning of the study who received oral estrogen treatment throughout the follow-up period. Group II comprised 10 girls with malnutrition and secondary amenorrhea with an evolution of less than one year who received nutritional treatment only. All parameters were compared with those of a control group of 19 healthy, age-matched girls with normal BMI and regular menstrual cycles. The OPG/RANKL ratio was significantly decreased (p<0.05) after 1 year in group I, a fact that was due to an increase (p<0.05) in serum RANKL values. A correlation between OPG/RANKL and BMD was found in group I at the beginning of the study (r = 0.95; p<0.001). Patients in this group showed lower BMD values (p<0.01), both at diagnosis and at the end of the study, than those of group II patients, who showed normal BMD values. The decrease in the OPG/RANKL ratio in girls with AN could partly explain the increase in bone loss that occurs in these patients.Keywords
This publication has 18 references indexed in Scilit:
- New contributions to the prevalence of eating disorders in Spanish adolescents: detection of false negativesEuropean Psychiatry, 2005
- Clinical Implications of the Osteoprotegerin/RANKL/RANK System for Bone and Vascular DiseasesJAMA, 2004
- The complex effects of leptin on bone metabolism through multiple pathwaysCurrent Opinion in Pharmacology, 2004
- Eating disorders: clinical features and pathophysiologyPhysiology & Behavior, 2004
- Characterization of Bone Structure in Leptin Receptor-Deficient Zucker (fa/fa) RatsJournal of Bone and Mineral Research, 2003
- Circulating Estradiol and Osteoprotegerin as Determinants of Bone Turnover and Bone Density in Postmenopausal WomenThe Journal of Clinical Endocrinology & Metabolism, 2002
- Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biologyJournal of Molecular Medicine, 2001
- A variation in Bone Alkaline Phosphatase levels that correlates positively with bone loss and normal levels of aminoterminal propeptide of collagen I in girls with anorexia nervosaClinica Chimica Acta, 1999
- Immunological Characterization of Circulating Osteoprotegerin/Osteoclastogenesis Inhibitory Factor: Increased Serum Concentrations in Postmenopausal Women with OsteoporosisJournal of Bone and Mineral Research, 1999
- Leptin plasma levels in healthy Spanish children and adolescents, children with obesity, and adolescents with anorexia nervosa and bulimia nervosaThe Journal of Pediatrics, 1997